Long term benefit of one year infliximab administration for the treatment of chronic refractory pouchitis

Journal of Crohn's and Colitis

Volumn 7, Issue 10, 2013, Pages

  Viazis, Nikos ^a   Giakoumis, Marios ^a   Koukouratos, Theodoros ^a   Anastasiou, Jiannis ^a   Katopodi, Konstantina ^a   Kechagias, Georgios ^a   Anastasopoulos, Elias ^a   Saprikis, Efstathios ^a   Chanias, Michail ^a   Tribonias, George ^a   Karamanolis, Dimitrios G ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Chronic refractory pouchitis; Infliximab; Pouch fistulae

Indexed keywords

CIPROFLOXACIN; ENEMA; INFLIXIMAB; METRONIDAZOLE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CAPSULE ENDOSCOPY; CHRONIC REFRACTORY POUCHITIS; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE ACTIVITY; ERYTHEMA NODOSUM; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; LONG TERM CARE; MALE; PRIORITY JOURNAL; REMISSION; TREATMENT RESPONSE; ULCERATIVE COLITIS;

CHRONIC REFRACTORY POUCHITIS; INFLIXIMAB; POUCH FISTULAE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ARTHRALGIA; CHRONIC DISEASE; COLITIS, ULCERATIVE; COLONIC POUCHES; CUTANEOUS FISTULA; ERYTHEMA NODOSUM; FEMALE; HUMANS; INTESTINAL FISTULA; MALE; POUCHITIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; URINARY BLADDER FISTULA;

EID: 84884133175     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.02.018     Document Type: Article

References (12)

1. Melville D., Ritchie J., Nicholls R., Hawley P. Surgery for ulcerative colitis in the era of the pouch: the St Mark's Hospital experience. Gut 1994, 35:1076-1080.
2. Fazio V., Ziv Y., Church J., Oakley J., Lavery I., Milsom J., et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995, 222:120-127.
3. Biancone L., Michetti P., Travis S., Escher J.C., Moser G., Forbes A., et al. European evidence-based consensus on the management of ulcerative colitis: special situations. J Crohns Colitis Mar 2008, 2(1):63-92.
4. Ferrante M., Declerck S., De Hertogh G., Van Assche G., Geboes K., Rutgeerts P., et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis 2008, 14:20-28.
5. Sandborn W., Pardi D. Clinical management of pouchitis. Gastroenterology 2004, 127:1809-1814.
6. Patel R., Bain I., Youngs D., Keighley M. Cytokine production in pouchitis is similar to that in ulcerative colitis. Dis Colon Rectum 1995, 38:831-837.
7. Colombel j., Ricart E., Loftus V., Tremaine W., Young-Fadok T., Dozois E., et al. Management of Crohn's disease of the ileoanal pouch with infliximab. Am J Gastroenterol 2003, 98:2239-2244.
8. Viscido a., Habib F., Kohn A., Papi C., Marcheggiano A., Pimpo M., et al. Infliximab in refractory pouchitis complicated by fistulae, following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther 2003, 17:1263-1271.
9. Calabrese C., Gionchetti P., Rizzello F., Liguori G., Gabusi V., Tambasco R., et al. Short term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther 2008, 27:759-764.
10. Shen B., Remzi F., Lavery I., Lopez R., Queener E., Shen L., et al. Administration of adalimumab in the treatment of Crohn's disease of the ileal pouch. Aliment Pharmacol Ther 2009, 29:519-526.
11. Li Y., Lopez R., Queener E., Shen B. Adalimumab therapy in Crohn's disease of the ileal pouch. Inflamm Bowel Dis 2012, 18:2232-2239.
12. Ferrante M., D'Haens G., Dewit O., Baert F., Holvoet J., Geboes K., et al. Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series. Inflamm Bowel Dis 2010, 16(2):243-249.